Result: Risk Minimisation Materials for medicines starting with the letter F
Fabrazyme
Sanofi Genzyme

Fabrazyme (agalsidase beta) - Home Infusion HCP Manual - Risk Minimisation Information for Healthcare Professionals
The objective of this document is to provide guidance to healthcare professionals for the management of patients receiving Fabrazyme (agalsidase beta) at home. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]
For Healthcare Professionals

Fabrazyme (agalsidase beta) - Home Infusion Patient Manual - Risk Minimisation Information for Patients
The objective of this document is to provide patients with guidance on how to receive Fabrazyme (agalsidase beta) at home. It is the responsibility of the treating physician to supply this material to patients only if the treating physician decides that the patient is eligible for home infusion treatment. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]
For Healthcare Professionals
Femodene
Bayer plc

CHCs - Checklist for Prescribers
Combined Hormonal Contraceptives - checklist for prescribers
For Healthcare Professionals

CHCs - Q&A on Important Info for Women
Combined hormonal contraceptives: Q&As about the important information for women.

CHCs - Risk of Blood Clots with CHCs
Important Information for women about risk of blood clots with combined hormonal contraceptives.
Femodene ED
Bayer plc

CHCs - Checklist for Prescribers
Combined Hormonal Contraceptives - checklist for prescribers
For Healthcare Professionals

CHCs - Q&A on Important Info for Women
Combined hormonal contraceptives: Q&As about the important information for women.

CHCs - Risk of Blood Clots with CHCs
Important Information for women about risk of blood clots with combined hormonal contraceptives.
Femodette
Bayer plc

CHCs - Checklist for Prescribers
Combined Hormonal Contraceptives - checklist for prescribers
For Healthcare Professionals

CHCs - Q&A on Important Info for Women
Combined hormonal contraceptives: Q&As about the important information for women.

CHCs - Risk of Blood Clots with CHCs
Important Information for women about risk of blood clots with combined hormonal contraceptives.
Flixabi
Biogen Biosimilars

Flixabi Healthcare Professional Brochure
IMPORTANT INFORMATION FOR HCPs ON SAFETY AND RISK MINIMISATION FOR INFLIXIMAB
For Healthcare Professionals

Flixabi Patient Alert Card
This Alert Card contains important safety information that patients need to be aware of before and during treatment with Flixabi.

Flixabi Screening Sheet
This screening sheet is intended for use by HCPs who are assessing patients being considered for infliximab therapy.
For Healthcare Professionals
Forxiga
AstraZeneca UK Limited

Forxiga (dapagliflozin) – Guide for Healthcare Professionals
Guide for Healthcare Professionals to minimise the risk of Diabetic Ketoacidosis (DKA)
For Healthcare Professionals

Forxiga (dapagliflozin) – Patient and carer Guide
For people with type 1 diabetes mellitus and their carers to minimise the risk of Diabetic Ketoacidosis (DKA)

Healthcare Professional Guide
Guide for Healthcare Professionals to minimise the risk of Diabetic Ketoacidosis (DKA)
For Healthcare Professionals

Patient Alert Card
Patient Alert Card

Patient and Carer Guide
For people with type 1 diabetes mellitus and their carers to minimise the risk of Diabetic Ketoacidosis (DKA)